Saturday, March 14, 2026
HomeHealthThe debate about the abortion pill mifepristone -resurfaces after Makary has been...

The debate about the abortion pill mifepristone -resurfaces after Makary has been confirmed to lead the FDA

Date:

Related stories

Many Americans wonder whether the pill used in most US abbreviations is restricted as part of the recent Republican administration in Washington.

The election of President Donald Trump, the Food and Drug Administration, Dr. Marty Makary, to lead, was confirmed by the Senate delayed Tuesday. In the recent statements before the Senate Health Committee, Makary would not commit himself to the specific measures of the pill called Mifepristone, even though they nudge from both Republicans and Democrats.

Doctors call it “the safest medication” that the FDA ever approved. But a Christian conservative group that sued the FDA about the medication says that it caused “tens of thousands” of “emergency complications”.

Here is what you should know about the security of Mifepriston, which is usually used with misoprostol in medication teases that wallow near two thirds of the abortions in the United States

What are the security limits for the apply of the abortion pill?

The FDA approved Mifepristone in 2000 as a secure and effective way to end early pregnancies. There are currently no personal requirements and the pill can be sent by post.

For example, the FDA did not treat Mifepriston for the first time, which in infrequent cases can lead to hazardous, excessive bleeding that requires emergency care. Strict security limit values ​​were placed for those who were able to prescribe and distribute them-specifically certified doctors and only as part of three obligatory personal dates, in which the patient received the medication. The doctors also had to be able to carry out emergency surgery in order to stop excess bleeding and an abortion process if the medication did not end pregnancy.

In the course of time, the FDA confirmed the security of Mifepriston and repeatedly made restrictions easier.

How often are there earnest problems?

Opponents of abortion say that the decision of the FDA 2021 caused the online prescription and the apply of Mifepriston shipping trades caused too much more “emergency complications”.

But this argument summarizes women who have a number of problems – from Mifepristone who do not work to people who may only have questions or concerns, but do not require medical care.

Ob-gyns say that a miniature part of the patients suffer “main” or “serious” undesirable events after taking Mifepriston.

A legal report that was submitted to the Supreme Court last year by a group of medical organizations, including the American College of Obstricians and gynecologists, says: “When using medication, vital undesirable events, excessive blood loss or hospital stays – are less than 0.32% of the patient with more than 50,000 patients on.”

The definition that scientists generally apply for earnest undesirable events includes blood transfusions, larger operations, hospital admissions and death, said Ushma Upadhyay, one of the authors of this study from 2015.

The prescription information contained in the packaging for Mifepriston tablets lists somewhat different statistics for the so -called “serious secondary reactions”. It quotes areas for how often different complications occur: 0.03% to 0.5% for transfusion; 0.2% for sepsis and 0.04% to 0.6% for hospital stays in connection with medication abortions. The areas reflect the results in various relevant studies, according to experts.

Why do patients go to the emergency room?

The labeling of Mifepristone lists a complication that most medical groups do not consider a earnest or vital disadvantage: visits to between 2.9% and 4.6%. The current FDA label lists as an option when patients experience longer severe bleeding, severe abdominal pain or persistent fever. But he visits do not always reflect major problems.

Some people may go there after an abortion of medication because they are checked out or want to have questions, but have no doctor, said Upadhyay, a public health scientist at the University of California in San Francisco. Others, she said, “I don’t want to go to her basic supplier because of her abortion” because Stigma.

A study that she wrote together in 2018 showed that a little more than half of the patients who visited the emergency room only received the care of the observation due to abortions.

How effective is the pill?

Mifepristone leads to a completed abortion in 97.4% of cases according to the US study in the FDA label.

In 2.6% of cases, however, surgical intervention is required. And pregnancy continues in 0.7% of cases.

This is compared to procedural abortion in a clinic in which the probability that the procedure does not end pregnancy, “extremely, extremely low”, is probably less than 0.1%, said Dr. Pratima Gupta, board member of the American College of Obstricians and Gynecologists.

“Every time a procedural abortation is carried out, the doctors ensure that it is a complete abortion.”

Gupa, who has carried out abortation procedures for more than 20 years, said that there are “very few complications from abortion – any kind of abortion, medication or procedural dropouts”.

A study suggested that this also applies to medication abdomances in a clinic, a doctor’s office or at home with the assist of telemedicine.

How is the security and effectiveness of Mifepriston compared to other drugs?

The FDA applies on a case -by -case basis, which weighs effectiveness, security and other factors.

No drug is 100% effective, and many common medication does not work for a significant part of the patient.

Antidepressants usually assist between 40% and 60% of people with depression. New antibiotics that were approved by the FDA often dissolve around 70% of the infections.

According to the FDA, around 6 million patients have taken Mifepriston since 2000. A review of the agency records in 2021, which are looking for deaths that are probably related to the medicine, identified 13 or 0.00027% of the patients.

Medical organizations that support Mifepriston’s availability say that the security of the drug in view of the deaths compared to “ibuprofen who take more than 30 million Americans on a certain day”. ___

The Department of Health and Science from Associated Press receives support from the Science and Educational Media Group of the Howard Hughes Medical Institute and Robert Wood Johnson Foundation. The AP is only responsible for all content.

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here